Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
29.01.24
/
50%
€21.00
Target price
29.01.25
€28.68
Performance (%)
15.24%
Price
08.08.24
€24.00
Summary
This prediction is currently active. The prediction currently has a performance of 15.24%. This prediction currently runs until 29.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | -0.826% | -0.826% |
iShares Core DAX® | 0.393% | -2.618% |
iShares Nasdaq 100 | 0.394% | -10.309% |
iShares Nikkei 225® | 1.038% | -8.365% |
iShares S&P 500 | -0.046% | -4.991% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat